Wednesday, December 30, 2009

US review of Pfizer vaccine not completed - Reuters


US review of Pfizer vaccine not completed
Reuters
Pfizer shares fell 2 cents to $18.48 in after-hours trading. They earlier closed down 6 cents at $18.50 on the New York Stock Exchange.


No comments:

Post a Comment